Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

CERILLIANT™ Zonisamide Solution, 1.0 mg/mL in Methanol, Sold by MilliporeSigma™ Supelco™

Certified reference material

Supplier:  MilliporeSigma Supelco Z0051ML

Catalog No. 01-002-189


Due to product restrictions, please to purchase or view availability for this product.

Explore available promotions

Description

Description

Zonisamide is a second-generation anticonvulsant approved for use as an adjunctive therapy in adults with partial-onset seizures, infantile spasm, mixed seizure types of Lennox-Gastaut syndrome, and generalized tonic-clonic seizure. Zonisamide is marketed in the US under the trade name Zonegran™.
TRUSTED_SUSTAINABILITY
Specifications

Specifications

67-56-1, 68291-97-4
MFCD00865316
1.0 mg/mL in methanol
Ampule
9.7°C (49.5°F) - closed cup
C8H8N2O3S
UN 1230 - class 3 - PG 2 - Methanol, solution
212.23
1 mL
Product Suggestions

Product Suggestions

Safety and Handling

Safety and Handling

H331-H370

H311

EINECSNumber : 200-659-6

Recommended Storage : -20°C

SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Provide Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

CERILLIANT is a registered trademark of Cerilliant Corporation